Skip to main content

Table 2 Interleukin 17 levels in pleural effusion of lung cancer patients a

From: Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients

Clinical variables Patients ( n) IL-17 (pg/ml) Mean ± SD P-value
Age (years)    0.343
  ≥60 38 27.08 ± 4.87  
  <60 40 19.92 ± 5.28  
Gender    0.259
  Male 36 21.23 ± 5.30  
  Female 42 19.87 ± 5.23  
Histologic type    0.491
  Adenocarcinoma 67 20.33 ± 6.12  
  Nonadenocarcinoma 11 21.52 ± 5.05  
ECOG PS    0.256
  0 or 1 50 19.99 ± 5.37  
  2 to 4 28 21.41 ± 5.21  
Cytologic examination    0.912
  Positive 60 20.46 ± 5.18  
  Negative 18 20.62 ± 6.12  
Stage    0.706
  M1a 54 20.34 ± 4.58  
  M1b 24 20.83 ± 6.01  
Location    0.751
  Right 50 20.34 ± 5.36  
  Left 28 20.15 ± 4.97  
  1. aECOG PS, Eastern Cooperative Oncology Group performance status; IL-17, Interleukin 17.